Enhancement patterns of intrahepatic mass-forming cholangiocarcinoma at multiphasic computed tomography and magnetic resonance imaging and correlation with clinicopathologic features

European Review for Medical and Pharmacological Sciences

Volumn 19, Issue 15, 2015, Pages 2786-2797

  Ciresa, M ^a   De Gaetano, A M ^a   Pompili, M ^a   Saviano, A ^a   Infante, A ^a   Montagna, M ^a   Guerra, A ^a   Giuga, M ^a   Vellone, M ^a   Ardito, F ^a   De Rose, A ^a   Giuliante, F ^a   Vecchio, F M ^a   Gasbarrini, A ^a   Bonomo, L ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Chronic liver disease; Dynamic enhancement pattern; Histological differentiation; Intrahepatic mass forming cholangiocarcinoma; Magnetic resonance imaging; Multidetector computed tomography

Indexed keywords

AGED; ALCOHOL LIVER CIRRHOSIS; ARTICLE; BILE DUCT CARCINOMA; BILE DUCT DILATATION; CELIAC ARTERY; CHRONIC LIVER DISEASE; CLINICAL FEATURE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC ERROR; FEMALE; HUMAN; LIVER PARENCHYMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; RESEARCH; TUMOR DIFFERENTIATION; TUMOR VOLUME; VELOCITY; ADULT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DISEASE COURSE; INCIDENCE; LIVER; MASS SCREENING; MIDDLE AGED; PATHOLOGY; PROCEDURES; RADIOGRAPHY;

ADULT; AGED; CHOLANGIOCARCINOMA; DISEASE PROGRESSION; FEMALE; HUMANS; INCIDENCE; LIVER; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPHASIC SCREENING; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 84942274741     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. PATEL T, SINGH P. Cholangiocarcinoma: emerging approaches to a challenging cancer. Curr Opin Gastroenterol 2007; 23: 317-323.
2. European HPB Association Consensus Conference on Cholangiocarcinoma. HPB 2008; 2: 71-147.
3. YANG JD, KIM B, SANDERSON SO, SAUVER J, YAWN BP, LARSON J, THERNEAU TM, ROBERTS LR, GORES GJ, KIM WR. Biliary tract cancers in Olmsted County, Minnesota, 1976-2008. Am J Gastroenterol 2012; 107: 1256-1262.
4. ZHOU Y, ZHAO Y, LI B, HUANG J, WU L, XU D,YANG J, HE J. Hepatitis viruses infection and risk of intrahepatic cholangiocarcinoma: evidence from a meta-analysis. BMC Cancer 2012; 12: 289-295.
5. PALMER WC, PATEL T. Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma. J Hepatol 2012; 57: 69-76.
6. OISHI N, KUMAR MR, ROESSLER S, JI J, FORGUES M, BUDHU A, ZHAO X, ANDERSEN JB, QH, JIA HL, QIN LX, YAMASHITA TH, HG WOO, KIM YJ, KANEKO S, TANG ZY, THORGEIRSSON SS, WANG XW. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelialmesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 2012; 56: 1792-1803.
7. LIVER CANCER STUDY GROUP OF JAPAN. Classification of primary liver cancer. Tokyo, Japan: Kanehara, 1997; pp. 6-8.
8. SOYER P, BLUEMKE DA, REICHLE R, CALHOUN PS, BLISS DF, SCHERRER A, FISHMAN EK. Imaging of intrahepatic cholangiocarcinoma: 1. Peripheral cholangiocarcinoma. Am J Roentgenol 1995; 165: 1427-1431.
9. LACOMIS JM, BARON RL, OLIVER JK, NALESNIK MA, FEDERLE MP. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 1997; 203: 98-104.
10. KIM TK, CHOI BI, HAN JK, CHO SG, HAN MC. Peripheral cholangiocarcinoma of the liver: two-phase spiral CT findings. Radiology 1997; 204: 539-543.
11. LOYER EM, CHIN H, DUBROW RA, DAVID CL, EFTEKHARI F, CHARNSANGAVEJ C. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with Quadruple Phase Helical CT - A Comparative Study. Radiology 1999; 212: 866-875.
12. MAETANI Y, ITOH K, WATANABE C, AMETANI F, YAMABE H, KONISHI J. MR imaging of intrahepatic cholangiocarcinoma with pathologic correlation. Am J Roentgenol 2001; 176: 1499-1507.
13. BRUIX J, SHERMAN M. American Association for the Study of Liver Disease (AASLD). Management of hepatocellular carcinoma: an update. Hepatology 2011; 53: 1020-1022.
14. EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER, EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012; 56: 908-943.
15. BRIDGEWATER J, GALLE PR, KHAN S, LLOVET JM, PARK JW, PATEL T, PAWLIK TM, GORES GJ. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma. J Hepatol 2014; 60: 1268-1289.
16. CHONG YS, KIM YK, LEE MW, KIM SH, LEE WJ, RHIM HC, LEE SJ. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI. Clin Radiol 2012; 67: 766-773.
17. VILANA R, FORNER A, BIANCHI L, GARCÍA-CRIADO A, RIMOLA J, DE LOPE CR, REIG M, AYUSO C, BRÚ C, BRUIX J. Intrahepatic peripheral cholangiocarcinoma in cirrhosis patients may display a vascular pattern similar to hepatocellular carcinoma on contrastenhanced ultrasound. Hepatology 2010; 51: 2020-2029.
18. GALASSI M, IAVARONE M, ROSSI S, BOTA S, VAVASSORI S, ROSA L, LEONI S, VENERANDI L, MARINELLI S, SANGIOVANNI A, VERONESE L, FRAQUELLI M, GRANITO A, GOLFIERI R, COLOMBO M, BOLONDI L, PISCAGLIA F. Patterns of appearance and risk of misdiagnosis of intrahepatic cholangiocarcinoma in cirrhosis at contrast enhanced ultrasound. Liver Int 2013; 33: 771-779.
19. KIM SJ, LEE JM, HAN JK, KIM KH, LEE JY, CHOI BI. Peripheral mass-forming cholangiocarcinoma in cirrhotic liver. Am J Roentgenol 2007; 189: 1428-1434.
20. KIM SA, LEE JM, LEE KB, KIM SH, YOON SH, HAN JK, CHOI BI. Intrahepatic mass-forming cholangiocarcinomas: enhancement patterns at multiphasic CT, with special emphasis on arterial enhancement pattern-correlation with clinicopathologic findings. Radiology 2011; 260: 148-157.
21. ARIIZUMI SI, KOTERA Y, TAKAHASHI Y, KATAGIRI S, CHEN IP, OTA T, YAMAMOTO M. Mass-forming Intrahepatic Cholangiocarcinoma with marked enhancement on arterial-phase computed tomography reflects favorable surgical outcomes. J Surg Oncol 2011; 104: 130-139.
22. KANG Y, LEE JM, KIM SH, HAN JK, CHOI BI. Intrahepatic mass-forming cholangiocarcinoma: enhancement patterns on gadoxetic acid-enhanced MR images. Radiology 2012; 264: 751-760.
23. XU J, IGARASHI S, SASAKI M, MATSUBARA T, YONEDA N, KOZAKA K, IKEDA H, KIM J, YU E, MATSUI O, NAKANUMA Y. Intrahepatic cholangiocarcinomas in cirrhosis are hypervascular in comparison with those in normal livers. Liver Int 2012; 32: 1156-1163.
24. NANASHIMA A, ABO T, MURATAMI G, MATSUMOTO A, TOU K, TAKESHITA H, KUNIZAKI M, HIDAKA S, SAKAMOTO I, HAYASHI H, FUKUDA T, KUDO T, NAGAYASU T. Intrahepatic cholangiocarcinoma: relationship between tumor imaging enhancement by measuring attenuation and clinicopathologic characteristics. Abdom Imaging 2013; 38: 785-792.
25. BOLL DT, MERKLE EM. Diffuse liver disease: strategies for hepatic CT and MR imaging. Radiographics 2009; 29: 1591-1614.
26. RIMOLA J, FORNER A, REIG M, VILANA R, DE LOPE CR, AYUSO C, BRUIX J. Cholangiocarcinoma in cirrhosis: absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma. Hepatology 2009; 50: 791-798.
27. EDGE S, BYRD D, COMPTON C. AJCC Cancer Staging Manual. 7th ed. New York: Springer-Verlag, 2010: 201-09.
28. IAVARONE M, PISCAGLIA F, VAVASSORI S, GALASSI M, SANGIOVANNI A, VENERANDI L, FORZENIGO LV, GOLFIERI R, BOLONDI L, COLOMBO M. Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. J Hepatol 2013; 58: 1188-1193.
29. PARK HJ, KIM YK F, PARK MY, LEE WJ. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma. Abdom Imaging 2013; 38: 793-801.
30. KIM SH1, LEE CH, KIM BH, KIM WB, YEOM SK, KIM KA, PARK CM. Typical and atypical imaging findings of intrahepatic cholangiocarcinoma using gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging. J Comput Assist Tomogr 2012; 36: 704-709.
31. JEONG HT, KIM MJ, CHUNG YE, CHOI JY, PARK YN, KIM KW. Gadoxetate disodium-enhanced MRI of mass-forming intrahepatic cholangiocarcinomas: Iimaging-histologic correlation. Am J Roentgenol 2013; 20: 603-611
32. TAMADA T, ITO K, SONE T, YAMAMOTO A, YOSHIDA K, KAKUBA K, TANIMOTO D, HIGASHI H, YAMASHITA T. Dynamic contrast-enhanced magnetic resonance imaging of abdominal solid organ and major vessel: comparison of enhancement effect between Gd-EOB-DTPA and Gd-DTPA. J Magn Reson Imaging 2009; 29: 636-640.
33. CAO J, HUANG L, LIU C, LI J, ZHANG X, SHEN J, LI J, LU L, XU F, YAN J, WU M, LAU WY, YAN Y. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: a clinicopathologic study of 35 resected cases. J Gastroenterol Hepatol 2013; 28: 1025-1031.
34. INABA K, SUZUKI S, SAKAGUCHI T, KOBAYASI Y, TAKEHARA Y, MIURA K, BABA S, NAKAMURA S, KONNO H. Double primary hepatic cancer (intrahepatic cholangiocarcinoma and hepatocellular carcinoma) in a patient with hepatitis C virus-related cirrhosis. J Hepatobiliary Pancreat Surg 2007; 14: 204-209.